Keyphrases
Anti-hepatitis
28%
Cost to Society
14%
Cost-effectiveness
14%
Disease Database
14%
Disease Incidence
14%
Disease Prevalence
14%
Economic Burden
100%
Epidemiology
100%
Health Care Services
28%
Health Resource Use
28%
Hepatitis A
14%
Hepatitis B Surface Antigen (HBsAg)
28%
Hepatitis C
14%
Hospital Admission
14%
Increased Incidence
14%
Increasing Prevalence
14%
Liver Disease
42%
Opportunity Cost
14%
Population-based Study
100%
Record Linkage
28%
Retrospective Observational Study
14%
Scotland
28%
Tayside
85%
Vaccination Cost
14%
Vaccine Effectiveness
14%
Viral Hepatitis
100%
Viral Hepatitis Infection
14%
Medicine and Dentistry
Cohort Effect
100%
Cost-Effectiveness Analysis
12%
Diseases
12%
Gene Linkage
25%
Health Care Cost
37%
Health Service
25%
Hepatitis A
12%
Hepatitis B Antigen
25%
Hepatitis C
12%
Hepatitis Virus
100%
Identified Patient
12%
Immunoglobulin M
12%
Infection
12%
Liver Disease
37%
Observational Study
12%
Prevalence
25%
Nursing and Health Professions
Cost Effectiveness Analysis
12%
Diseases
12%
Health Care
25%
Health Care Planning
25%
Hepatitis A
12%
Hepatitis B Antigen
25%
Hepatitis C
12%
Immunoglobulin M
12%
Infection
12%
Liver Disease
37%
Prevalence
25%
Virus Hepatitis
100%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
12%
Hepatitis A
12%
Hepatitis B Antigen
25%
Hepatitis C
12%
Immunoglobulin M
12%
Infection
12%
Liver Disease
37%
Observational Study
12%
Prevalence
25%
Virus Hepatitis
100%